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Abstract
Background: The beneficial effects of the transcatheter aortic valve implantation (TAVI) on 
echocardiographic parameters including left atrial (LA) and left ventricular (LV) functions 
were described by previous studies. The aim of this study was to analyze the effects of TAVI on 
left atrial appendage (LAA) function assessed by transthoracic and transesophageal echocar-
diography.
Methods: Fifty-five patients with severe symptomatic aortic stenosis were included in this 
prospective study. LAA early and late emptying velocities, LAA filling velocity, peak early di-
astolic (EM), late diastolic (AM), and systolic (SM) velocities were measured with pulsed wave 
Doppler and tissue Doppler imaging, and E/Em ratio was calculated before and 7.1 ± 2.8 days 
after TAVI. A subgroup analysis was performed in accordance with the left ventricular ejection 
fraction (LVEF) of the patients and the severity of their LV diastolic dysfunction.
Results: Although the post-procedure peaks and mean gradients of the patients decreased sig-
nificantly, the LVEF increased significantly in those who had low LVEF before the procedure. 
The post-procedure E/Em ratio decreased significantly (p < 0.001). The post-procedural LAA 
mean filling velocity and EM velocity were significantly higher than the pre-procedural filling 
velocity (p < 0.001, p = 0.002, respectively). In the subgroup analysis, the post-procedural LAA 
filling velocity, early and late LAA emptying velocities, in addition to the mean velocity of the EM, 
AM, and SM were significantly higher than before the procedure in patients with LVEF of < 50%  
and E/Em ratios of > 15.
Conclusions: LAA function improved soon after the TAVI procedure, especially in patients 
with low LVEF and marked LV diastolic dysfunction. (Cardiol J 2015; 22, 5: 527–534)
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Introduction
Aortic stenosis (AS) leads to severe left ven-
tricular (LV) hypertrophy and impaired relaxation 
of the LV, resulting in LV diastolic dysfunction [1]. 
In advanced-stage AS, the contractile functions of 
myocardial cells are reduced and LV systolic func-
tions are impaired. The subsequent chronic pres-
sure and volume overload into the LV adversely 
affect the functions of the left atrial (LA) and the 
LA appendage (LAA) [2, 3].
Transcatheter aortic valve implantation (TAVI) 
has emerged as an alternative method of surgical 
aortic valve replacement for symptomatic patients 
with severe AS and with very high or prohibi-
tive operative risks [4]. Recent studies that used 
speckle-tracking echocardiography reported an 
improvement in some LA functions after TAVI in 
high-risk AS patients [5–7]. Although the beneficial 
effect of TAVI on clinical and echocardiographic 
hemodynamic parameters is well known, there 
are no data in the literature regarding the effect of 
this procedure on LAA functions. In this study, the 
functions of the LAA were compared before and 
approximately 1 week after the TAVI procedure 
pulsed wave (PW) Doppler and the tissue Doppler 
imaging (TDI) with transesophageal echocardio-
graphy (TEE) technique.
Methods
Study design and patient selection: This study 
enrolled 78 consecutive patients from January 
2011 to December 2014 who had symptomatic 
aortic valve stenosis New York Heart Associa-
tion (NYHA) functional class ≥ II and documented 
calcific aortic valve stenosis, with an initial aortic 
valve area (AVA) of < 1.0 cm2 (or an AVA index 
of < 0.6 cm2/m2) and a mean pressure gradient of 
> 40 mm Hg or a jet velocity of > 4 m/s, as meas-
ured by transthoracic echocardiography (TTE). 
The patients were deemed high risk based on the 
Society of Thoracic Surgery (STS) score of ≥ 10%, 
a logistic EuroSCORE of ≥ 20%, or agreement by 
a multidisciplinary heart team that frailty and/or 
coexisting comorbidities would be associated with 
a high surgical risk [8, 9]. The study’s exclusion 
criteria were the following: a congenital unicuspid 
or bicuspid aortic valve, an acute myocardial infarc-
tion, a transient ischemic attack, or a stroke within 
previous 6 months. Additional exclusion criteria 
were any permanent neurological defects, severe 
renal insufficiency, a pre-existing prosthetic heart 
valve or a prosthetic ring in any position, more 
than moderate (> 3+) mitral regurgitation or 
aortic regurgitation, untreated clinically significant 
coronary artery disease and a documented LV ejec-
tion fraction (LVEF) below 30%. In patients with 
a thrombus or severe spontaneous echo contrast 
(> 2+) in the LAA, which is a contraindication 
for the TAVI procedure, were excluded from this 
study. After the initial evaluation, 23 subjects were 
excluded from further analysis. Finally, 55 patients 
were included in the study. Patient demographics 
and medical history were obtained by the attending 
physicians. The Edwards Sapien XT transcatheter 
aortic valve system (Edwards Life Sciences, Irvine, 
CA, US) was used in all cases, with the patients 
under general anesthesia. The study complied with 
the Declaration of Helsinki, and the trial protocol 
was approved by the Institutional Ethics Commit-
tee of the hospital.
Echocardiographic study
All the patients underwent TTE and TEE 
(General Electric Vivid 7 GE Vingmend Ultra-
sound AS, Horten, Norway) before the procedure 
and again the first week after TAVI, according to 
the recommendations of the American Society 
of Echocardiography [10–11]. Two independent 
experienced physicians who were blinded to the 
patients’ clinical characteristics performed all the 
echocardiographic measurements. The patients’ 
blood pressure was measured prior to all of the 
procedures.
TTE parameters
LV systolic function was assessed by calculat-
ing the patients’ LVEF with 4-chamber Simpson’s 
method. LV diastolic performance was evaluated 
using PW Doppler and TDI. The LV diastolic inflow 
velocities were obtained from the apical 4-chamber 
view by placing the sample volume at the level 
of the mitral valve tip. Peak early diastolic flow 
(E) and peak atrial filling flow velocities (A) were 
measured. TDI of the velocities of longitudinal 
mitral annular motion were recorded at the septal 
and lateral mitral annular borders, the average of 
the results obtained. The early diastolic (Em), and 
late diastolic (Am) Doppler tissue velocities of the 
mitral annulus were measured, and the ratio of 
mitral inflow E velocity to tissue Doppler (E/Em) 
for both septal and lateral walls was calculated, the 
average of the results was obtained.
TEE parameters
All the patients were instructed not to take 
water or food for at least 4 h. The patients’ oro-
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pharynx was anesthetized with a topical lidocaine 
10% spray. Sedation with midazolam was used 
if needed. TEE was performed with a 5 MHz 
multiplane transesophageal probe. The LAA was 
visualized in the mid-esophageal 2-chamber view 
by rotation of the imaging sector from 50o to 90o. 
The LAA emptying and filling flow velocities were 
also recorded by PW Doppler, with a 2 × 2 mm 
sampling volume placed at the one-third proximal 
position of the LAA cavity. During the assessment 
of LAA flow, 2 blood flow velocities were evaluated. 
An early diastolic outflow wave observed before 
the electrocardiographic P wave was termed V1. 
Biphasic waves following V1 subsequent to the 
P wave were termed V2 (late emptying flow veloc-
ity) and V3 (filling flow velocity) (Fig. 1). The peak 
flow velocities of the V1, V2, and V3 waves were 
measured.
LAA TDI velocities
In the TDI analysis, the spectral mode of the 
PW Doppler sample volume of the LAA lateral 
wall was placed midway between the LAA tip and 
outlet. In sinus rhythm, 3 distinct velocities were 
recorded. The first positive wave after the elec-
trocardiographic P wave was termed AM, followed 
by a negative wave (SM), which coincided with LV 
contraction, and then a positive wave (EM) during 
LV relaxation. A representative illustration of the 
LAA TDI velocities of a patient pre- and post-TAVI 
is shown in Figure 1.
Statistical analysis
Continuous variables are expressed as mean 
± standard deviation. Categorical variables were 
expressed as frequencies and/or percentages. The 
Kolmogorov–Smirnov test was used to evaluate 
whether the continuous variables were normally 
distributed. The “paired samples test” was used 
to compare the before and after TAVI procedure 
results. A p value of less than 0.05 was considered to 
indicate statistical significance. Statistical analyses 
were carried out using the Number Cruncher Statis-
tical System 2007 Statistical Software (Utah, USA).
Results
The baseline characteristics of the study 
patients are presented in Table 1. The mean age 
was 77.3 ± 6.9 years, and 36 (65%) patients were 
female. The mean logistic EuroSCORE and STS 
score were 27.5 ± 14.2 and 12.3 ± 6.6, respec-
tively. Before the TAVI procedure, the diameter of 
the LA was 43.7 ± 6.0 mm and that of the aortic 
valve effective orifice area was 0.76 ± 0.17 cm2. 
When systolic blood pressures were compared in 
Figure 1. Effect of transcatheter aortic valve implantation on left atrial appendage Doppler velocities: before (A), after (B) 
and Doppler tissue velocities: before (C), after (D).
A B
C D
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terms of before vs. after TAVI procedure, no sig-
nificant differences were found (before: 125 ± 12.3 
mm Hg vs. after: 132 ± 13.1 mm Hg, p = 0.106).
TTE
TTE 2-dimensional and Doppler parameters 
before and after the procedure are given in Table 2. 
The mean and peak pressure gradients were signifi-
cantly reduced after the TAVI procedure (p < 0.001). 
Moreover, there was no difference between pre- 
and post-procedural LVEFs in the patients with 
AS (p = 0.054). However, in the subgroup analysis, 
the post-procedural LVEF was higher in the low 
LVEF group (p = 0.003). The post-procedural 
means of the E/Em were also significantly lower 
compared to the pre-procedural means (p < 0.001).
TEE
The comparison of the TEE PW Doppler and 
TDI parameters of pre- and post-procedural LAA 
functions in all the patients is reported in Table 2. 
Subgroup analyses were performed based on the 
LVEF (LVEF < 50% and LVEF > 50%) (Table 3) 
and diastolic dysfunction parameters (E/Em > 15 
and E/Em < 15) of the patients (Table 4). The post-
-procedural means of LAA filling velocities were 
significantly higher compared to the pre-procedural 
means in all study groups (p < 0.001). When the 
results of the subgroup analyses of the low and 
preserved LVEF groups were compared, the post-
-procedural means of LAA filling velocities were 
significantly higher compared to the pre-procedural 
means in both the low and preserved LVEF groups 
(p = 0.001 and p = 0.021, respectively). In the 
low LVEF group, the post-procedural means of 
the LAA early and late emptying velocities were 
significantly higher compared to the pre-procedural 
means (p = 0.022 and p = 0.036, respectively). 
However, the post-procedural means of the LAA 
early and late emptying velocities were not differ-
ent from the pre-procedural means in the preserved 
LVEF group. In the TDI analysis, although the 
post-procedural velocities of the peak early dias-
tolic (EM), peak late diastolic (AM), and peak systolic 
(SM) were increased, only the increase in the EM 
velocity was significantly higher (p = 0.002). In 
the subgroup analysis, the post-procedural veloci-
ties of EM, AM, and SM were significantly increased 
in the low LVEF group (Table 3). Despite the in-
crease in the post-procedural velocities of these 
parameters, there was no significant difference 
between the pre- and post-procedural velocities 
in the preserved LVEF group (Table 3). Moreover, 
the post-procedural means of LAA filling, early and 
late emptying velocities were significantly higher 
than the pre-procedural means in the patients 
with diastolic dysfunction (E/Em > 15). In the TDI 
analysis, the post-procedural velocities of EM, AM, 
and SM were significantly increased in the patients 
with diastolic dysfunction (E/Em > 15) (Table 4). 
However, there was no significant difference in 
the post-procedural LAA filling and emptying 
velocities or the LAA tissue Doppler velocities 
in the patients with preserved diastolic function 
(E/Em < 15) (Table 4).
Table 1. Baseline patient characteristics (n = 55).
Variable Value
Age [years] 77.3 ± 6.9
Female 36 (65%)
Logistic EuroSCORE [%] 27.5 ± 14.2
STS score [%] 12.3 ± 6 .6
Body mass index [kg/m2] 28.0 ± 4.5
Hypertension 39 (70%)
Diabetes 26 (47%)
Coronary artery disease 33 (60%)
Cerebrovascular event 4 (7%)
Smoker 18 (32%)
Creatinine [mg/dL] 1.0 ± 0.7
LDL-C [mg/dL] 111 ± 35
WBC [k/mm3] 7.0 ± 1.7
HGB [g/dL] 11.8 ± 1.6
LVEF < 50% 21 (39%)
LVDD (E/Em > 15) 22 (40%)
Effective orifice area [cm2] 0.76 ± 0.17
LA diameter [mm] 43.7 ± 6.0
Time to echocardiography  
after implantation [days]
7.1 ± 2.8
Aortic valve prosthesis:  
— Edwards SAPIEN XT: 
23 mm 18 (32.7%)
26 mm 23 (41.8%)
29 mm 14 (25.5%)
LA diameter [mm] 43.7 ± 6.0
SBP [mm Hg]: P = 0.106
Before 125 ± 12.3
After 132 ± 13.1
Mean values (standard deviation) and % (n) are reported for contin-
uous and categorical variables; STS — Society of Thoracic Surgery 
score; LDL-C — low density lipoprotein cholesterol; WBC — white 
blood cell; HGB — hemoglobin; LVEF — eft ventricular ejection 
fraction; LVDD — left ventricular diastolic dysfunction; LA — left 
atrium; SBP — systolic blood pressure
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Discussion
Previous studies described the beneficial ef-
fects of the TAVI procedure on clinical, hemody-
namic, and echocardiographic parameters including 
LA and LV functions, in patients with severe AS 
[12–15]. However, there are no data in the litera-
ture regarding the effects of TAVI on the functions 
of the LAA. In this study, we used TTE and TEE to 
evaluate pre- and post-procedural (7.1 ± 2.8 days) 
LAA functions. We demonstrated, for the first time, 
an improvement in LAA functions detected by PW 
Doppler and TDI approximately 1 week after the 
TAVI procedure, especially in patients with marked 
diastolic dysfunction (E/Em > 15) and a low LVEF 
(< 50%).
In advanced-stage AS, volume overload, which 
is caused by a depressed LVEF, impairs LA and 
Table 2. Comparison of TTE and TEE variables before and after TAVI.
Before After P 
TTE: 2D and Doppler parameters
LVEF [%]:
All 53.1 ± 12.3 54.3 ± 10.2 0.054
< 50% 39.4 ± 8.4 43.1 ± 7.2 0.003
> 50% 61.6 ± 3.2 61.2 ± 3.6 0.319
Peak aortic gradient [mm Hg] 84.2 ± 21.7 18.8 ± 9.6 < 0.001
Mean aortic gradient [mm Hg] 52.8 ± 14.3 10.3 ± 5.0 < 0.001
E velocity [cm/s] 95.5 ± 34.3 91.0 ± 32.7 0.230
Em velocity [cm/s] 7.1 ± 2.1 8.0 ± 2.2 < 0.001
E/Em 13.7 ± 4.6 11.5 ± 4.1 < 0.001
TEE: Doppler and TDI parameters
LAA emptying velocity [cm/s] 37.8 ± 16.1 39.5 ± 16.1 0.129
LAA filling velocity [cm/s] 38.8 ± 10.6 42.3 ± 12.0 < 0.001
EM [cm/s] 7.8 ± 3.8 8.9 ± 4.0 0.002
AM [cm/s] 14.4 ± 6.1 15.6 ± 6.2 0.065
SM [cm/s] 13.1 ± 6.0 14.2 ± 6.3 0.091
Mean values (standard deviation) are reported for continuous variables; TTE — transthoracic echocardiography; TEE — transesophageal 
echocardiography; TAVI — transcatheter aortic valve implantation; LAA — left atrial appendage; TDI — tissue Doppler imaging
Table 3. Comparison of LAA function before and after TAVI by TEE with LVEF.
Parameter Before After P 
LVEF > 50%
LAA emptying velocity [cm/s] 46.0 ± 14.0 46.8 ± 15.8 0.578
LAA filling velocity [cm/s] 43.3 ± 9.9 45.8 ± 11.7 0.021
EM [cm/s] 9.4 ± 3.5 10.1 ± 3.7 0.182
AM [cm/s] 16.9 ± 5.4 17.5 ± 6.1 0.533
SM [cm/s] 16.0 ± 5.7 16.1 ± 6.7 0.865
LVEF < 50%
LAA emptying velocity [cm/s] 24.6 ± 9.0 27.6 ± 7.2 0.036
LAA filling velocity [cm/s] 31.5 ± 7.4 36.6 ± 10.3 0.001
EM [cm/s] 5.2 ± 2.6 7.2 ± 3.7 < 0.001
AM [cm/s] 9.2 ± 3.6 11.8 ± 4.6 0.007
SM [cm/s] 8.6 ± 2.9 11.0 ± 3.9 < 0.001
Mean values (standard deviation) are reported for continuous variables. LAA — left atrial appendage; TEE — transesophageal echocardiogra-
phy; TAVI — transcatheter aortic valve implantation; LVEF — left ventricular ejection fraction
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LAA functions. This impairment leads to a de-
crease in the LAA velocities, the LAA Doppler 
tissue velocities, and the mechanical functions 
between the LA–LAA [2, 16, 17]. LV function is 
an important predictor of LAA velocity. A previ-
ous study reported a relationship between a low 
LVEF and LAA dysfunction. Moreover, reduced 
LAA velocities in non-valvular atrial fibrillation and 
LV systolic dysfunction were presented in recent 
studies [18–20].
Transcatheter valve implantation offers 
a new treatment modality for patients who have 
multiple comorbidities that make conventional 
surgery a high risk [21]. Recent studies reported 
an improvement in LA functions after the TAVI 
procedure in high-risk patients with systolic and 
diastolic dysfunction [5–7]. In the present study, 
the amelioration of LAA functions soon after the 
TAVI procedure may have been due to the marked 
and beneficial effects of the procedure on hemody-
namic and echocardiographic parameters.
D’Andrea et al. [5] have recently used speckle-
-tracking echocardiography to demonstrate an 
improvement in the LA longitudinal function of 
patients with severe AS 6 months after they had 
undergone the TAVI procedure. Spethmann et al. 
[7] demonstrated that a global and regional LV and 
LA mechanics improved 12 months after TAVI. 
LA function was evaluated with speckle-tracking 
echocardiography in previous TAVI studies [5–7]. 
To the best of our knowledge, this is the first study 
to assess LAA functions after TAVI procedure 
in patients with severe AS. In this study, LAA 
Table 4. Comparison of LAA function before and after TAVI by TEE with E/Em.
Parameter Before After P 
E/Em > 15
LAA emptying velocity [cm/s] 30.6 ± 13.4 36.1 ± 16.7 0.001
LAA filling velocity [cm/s] 35.5 ± 9.8 41.7 ± 11.4 < 0.001
EM [cm/s] 6.6 ± 3.0 9.0 ± 3.7 < 0.001
AM [cm/s] 11.8 ± 4.9 15.2 ± 6.0 < 0.001
SM [cm/s] 11.3 ± 5.3 14.3 ± 6.1 < 0.001
E/Em < 15
LAA emptying velocity [cm/s] 42.6 ± 16.1 41.8 ± 15.6 0.552
LAA filling velocity [cm/s] 41.0 ± 10.7 42.7 ± 12.5 0.091
EM [cm/s] 8.6 ± 4.0 8.9 ± 4.2 0.490
AM [cm/s] 15.9 ± 6.3 15.8 ± 6.4 0.829
SM [cm/s] 14.4 ± 6.2 14.0 ± 6.5 0.683
Mean values (standard deviation) are reported for continuous variables; LAA — left atrial appendage; TEE — transesophageal echocardiogra-
phy; TAVI — transcatheter aortic valve implantation
filling velocities significantly increased in the 
post-procedural period. Although LAA emptying 
velocities were elevated after the TAVI procedure 
in this population, the increase was significant 
only in the low LVEF group. Spethmann et al. [6] 
demonstrated an improvement only in reservoir 
and conduit functions in the early period after the 
TAVI procedure. However, their study contained no 
information on the relationship between reservoir 
and conduit functions and LVEF. In this study, 
a significant increase in the post-procedural LAA 
tissue Doppler velocities in the low LVEF group 
was detected.
Different studies demonstrated depressed LA 
or LAA functions due to LV mass, LV outflow tract 
gradients, and LV diastolic dysfunction [22–24]. 
Moreover, the functions of LA booster-pump were 
found to be related to symptoms of severe AS in 
patients with preserved LVEF [22]. Although the 
velocities of the E/Em and Em have a close relation-
ship with systolic function, recent studies reported 
that this parameter reflected the functions of the 
LAA, independent of the LVEF [23–25].
In conclusion, the LA functions as a conduit of 
LV in early diastole and diastasis phases. Hence, 
it is affected directly by end-diastolic pressure 
and diastolic functions of the LV. The LA is also 
affected directly by compliance and pressure of 
the LV because it functions as a pump of the LV at 
the end of diastole [25–27]. In our study, the E/Em 
was decreased in the post-procedural period. In 
the subgroup analysis, the post-procedural LAA 
filling velocity, LAA emptying velocity, and mean 
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velocities of the EM, AM, and SM were significantly 
higher than those during the pre-procedural pe-
riod in patients with an E/Em of > 15. However, 
this study has not revealed any difference in the 
post-procedural LAA functions in patients with an 
E/Em of < 15.
As a result of these data, the early increase in 
the functions of LAA may be due to improved post-
-procedural hemodynamic parameters, including 
elevated LVEFs and improved diastolic function, 
especially in patients with marked systolic and 
diastolic dysfunction. This improvement may be 
expected in long-term follow-up of patients with 
preserved LVEFs and diastolic function, because 
LA and LV remodeling takes much time.
Limitations of the study
This was a single-center study with a rela-
tively small sample size, both of which limit the 
power of our research findings. Lack of follow-up 
of the patients in terms of short- and long-term 
cardiovascular events and link to the patients 
outcomes were the most serious weaknesses of 
our manuscript. Moreover, the lack of long-term 
follow-up of the echocardiographic parameters was 
another limitation of the present study. As atrial 
fibrillation is a common arrhythmia in patients with 
valvular heart disease, this was not an exclusion 
criterion. In our study, only 6 patients had chronic 
atrial fibrillation, and therefore ALAA was not evalu-
ated in these patients.
Conclusions
In this study, we demonstrated that successful 
TAVI improved the echocardiographic hemody-
namic status and increased the LAA Doppler and 
TDI velocities, which lead to improved regional 
LAA function in patients with a depressed LVEF, 
and increased LV diastolic dysfunction. Thus, the 
relief of AS by TAVI may not only confer hemody-
namic benefits resulting in symptomatic improve-
ment, but also have a favorable influence on LA 
and LAA function.
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